Selective blockade of the inhibitory Fcγ receptor (Fcγ RIIB) in human dendritic cells and monocytes induces a type I interferon response program

被引:117
作者
Dhodapkar, Kavita M.
Banerjee, Devi
Connolly, John
Kukreja, Anjli
Matayeva, Elyana
Veri, Maria Concetta
Ravetch, Jeffrey V.
Steinman, Ralph M.
Dhodapkar, Madhav V.
机构
[1] Rockefeller Univ, Cellular Physiol & Immunol Lab, New York, NY 10021 USA
[2] Rockefeller Univ, Lab Mol Genet & Immunol, New York, NY 10021 USA
[3] Rockefeller Univ, Lab Tumor Immunol & Immunotherapy, New York, NY 10021 USA
[4] Rockefeller Univ, Chris Browne Ctr Immunol, New York, NY 10021 USA
[5] MacroGen Inc, Rockville, MD 20850 USA
[6] Baylor Inst Immunol Res, Dallas, TX 75204 USA
关键词
D O I
10.1084/jem.20062545
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The ability of dendritic cells (DCs) to activate immunity is linked to their maturation status. In prior studies, we have shown that selective antibody-mediated blockade of inhibitory Fc gamma RIIB receptor on human DCs in the presence of activating immunoglobulin (Ig) ligands leads to DC maturation and enhanced immunity to antibody-coated tumor cells. We show that Fc gamma receptor (Fc gamma R) - mediated activation of human monocytes and monocyte-derived DCs is associated with a distinct gene expression pattern, including several inflammation-associated chemokines, as well as type 1 interferon (IFN) response genes, including the activation of signal transducer and activator of transcription 1 (STAT1). Fc gamma R-mediated STAT1 activation is rapid and requires activating Fc gamma Rs. However, this IFN response is observed without a detectable increase in the expression of type I IFNs themselves or the need to add exogenous IFNs. Induction of IFN response genes plays an important role in Fc gamma R-mediated effects on DCs, as suppression of STAT1 by RNA interference inhibited Fc gamma R-mediated DC maturation. These data suggest that the balance of activating/inhibitory Fc gamma Rs may regulate IFN signaling in myeloid cells. Manipulation of Fc gamma R balance on DCs and monocytes may provide a novel approach to regulating IFN-mediated pathways in autoimmunity and human cancer.
引用
收藏
页码:1359 / 1369
页数:11
相关论文
共 39 条
[1]   Induction of dendritic cell differentiation by IFN-α in systemic lupus erythematosus [J].
Blanco, P ;
Palucka, AK ;
Gill, M ;
Pascual, V ;
Banchereau, J .
SCIENCE, 2001, 294 (5546) :1540-1543
[2]   Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions [J].
Boruchov, AM ;
Heller, G ;
Veri, MC ;
Bonvini, E ;
Ravetch, JV ;
Young, JW .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (10) :2914-2923
[3]   Mechanisms of disease - The many roles of chemokines and chemokine receptors in inflammation [J].
Charo, IF ;
Ransohoff, RM .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (06) :610-621
[4]   Fc receptor biology [J].
Daeron, M .
ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :203-234
[5]   JAK-STAT PATHWAYS AND TRANSCRIPTIONAL ACTIVATION IN RESPONSE TO IFNS AND OTHER EXTRACELLULAR SIGNALING PROTEINS [J].
DARNELL, JE ;
KERR, IM ;
STARK, GR .
SCIENCE, 1994, 264 (5164) :1415-1421
[6]   Recruiting dendritic cells to improve antibody therapy of cancer [J].
Dhodapkar, KM ;
Dhodapkar, MV .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (18) :6243-6244
[7]   Selective blockade of inhibitory Fcγ receptor enables human dendritic cell maturation with IL-12p70 production and immunity to antibody-coated tumor cells [J].
Dhodapkar, KM ;
Kaufman, JL ;
Ehlers, M ;
Banerjee, DK ;
Bonvini, E ;
Koenig, S ;
Steinman, RM ;
Ravetch, JV ;
Dhodapkar, MV .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (08) :2910-2915
[8]   Antitumor monoclonal antibodies enhance cross-presentation of cellular antigens and the generation of myeloma-specific kill T cells dentritic cells [J].
Dhodapkar, KM ;
Krasovsky, J ;
Williamson, B ;
Dhodapkar, MV .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (01) :125-133
[9]   A critical function for type I interferons in cancer immunoediting [J].
Dunn, GP ;
Bruce, AT ;
Sheehan, KCF ;
Shankaran, V ;
Uppaluri, R ;
Bui, JD ;
Diamond, MS ;
Koebel, CM ;
Arthur, C ;
White, JM ;
Schreiber, RD .
NATURE IMMUNOLOGY, 2005, 6 (07) :722-729
[10]   Natural adjuvants: Endogenous activators of dendritic cells [J].
Gallucci, S ;
Lolkema, M ;
Matzinger, P .
NATURE MEDICINE, 1999, 5 (11) :1249-1255